> top > docs > PubMed:34015499 > annotations

PubMed:34015499 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-169 Sentence denotes Twelve weeks' treatment with a polyphenol-rich seaweed extract increased HDL cholesterol with no change in other biomarkers of chronic disease risk in overweight adults:
T2 170-208 Sentence denotes A placebo-controlled randomized trial.
T3 209-277 Sentence denotes Cardiovascular diseases (CVD) are the leading global cause of death.
T4 278-328 Sentence denotes Strategies to reduce CVD risk are urgently needed.
T5 329-498 Sentence denotes Polyphenols represent a class of bioactive compounds with potential to moderate biochemical risk factors for CVD (cholesterol, triglycerides, glucose, and inflammation).
T6 499-687 Sentence denotes This double-blind, placebo-controlled, randomized parallel-groups trial investigated the effect of a polyphenol-rich seaweed (Fucus vesiculosus) extract on biochemical markers of CVD risk.
T7 688-899 Sentence denotes Thirty-four overweight and obese adults (21 female, 13 male) with elevated low-density lipoprotein cholesterol (>2.0 mmol/L) were randomized to either the seaweed extract (2000 mg/d) or placebo for twelve weeks.
T8 900-1005 Sentence denotes Fasting blood samples were collected at baseline, week six and week twelve to assess biochemical markers.
T9 1006-1099 Sentence denotes Tests of cognitive performance and mood were performed at baseline, week six and week twelve.
T10 1100-1269 Sentence denotes A 9.5% (-2.3, 12.9) increase in high-density lipoprotein (HDL) cholesterol was identified following the seaweed extract (baseline: mean (SD) 1.28 (0.23) mmol/L, week 12:
T11 1270-1331 Sentence denotes 1.35 (0.24) mmol/L) which was different to placebo (baseline:
T12 1332-1360 Sentence denotes 1.38 (0.54) mmol/L, week 12:
T13 1361-1390 Sentence denotes 1.35 (0.59) mmol/L) (P=.045).
T14 1391-1679 Sentence denotes No changes were identified in low-density lipoprotein cholesterol, total cholesterol, triglycerides, glucose, insulin, interleukin (IL)-2, IL-6, IL-8, IL-10, or tumour necrosis factor-alpha levels in the blood, or in cognitive performance or mood between the treatment and placebo groups.
T15 1680-1839 Sentence denotes Despite the small increase observed in HDL cholesterol, the polyphenol-rich seaweed extract did not change CVD risk factors in adults with high fasting lipids.
T16 1840-1947 Sentence denotes A larger sample size would be required to confirm the clinical relevance of the changes in HDL cholesterol.
T1 0-169 Sentence denotes Twelve weeks' treatment with a polyphenol-rich seaweed extract increased HDL cholesterol with no change in other biomarkers of chronic disease risk in overweight adults:
T2 170-208 Sentence denotes A placebo-controlled randomized trial.
T3 209-277 Sentence denotes Cardiovascular diseases (CVD) are the leading global cause of death.
T4 278-328 Sentence denotes Strategies to reduce CVD risk are urgently needed.
T5 329-498 Sentence denotes Polyphenols represent a class of bioactive compounds with potential to moderate biochemical risk factors for CVD (cholesterol, triglycerides, glucose, and inflammation).
T6 499-687 Sentence denotes This double-blind, placebo-controlled, randomized parallel-groups trial investigated the effect of a polyphenol-rich seaweed (Fucus vesiculosus) extract on biochemical markers of CVD risk.
T7 688-899 Sentence denotes Thirty-four overweight and obese adults (21 female, 13 male) with elevated low-density lipoprotein cholesterol (>2.0 mmol/L) were randomized to either the seaweed extract (2000 mg/d) or placebo for twelve weeks.
T8 900-1005 Sentence denotes Fasting blood samples were collected at baseline, week six and week twelve to assess biochemical markers.
T9 1006-1099 Sentence denotes Tests of cognitive performance and mood were performed at baseline, week six and week twelve.
T10 1100-1269 Sentence denotes A 9.5% (-2.3, 12.9) increase in high-density lipoprotein (HDL) cholesterol was identified following the seaweed extract (baseline: mean (SD) 1.28 (0.23) mmol/L, week 12:
T11 1270-1331 Sentence denotes 1.35 (0.24) mmol/L) which was different to placebo (baseline:
T12 1332-1360 Sentence denotes 1.38 (0.54) mmol/L, week 12:
T13 1361-1390 Sentence denotes 1.35 (0.59) mmol/L) (P=.045).
T14 1391-1679 Sentence denotes No changes were identified in low-density lipoprotein cholesterol, total cholesterol, triglycerides, glucose, insulin, interleukin (IL)-2, IL-6, IL-8, IL-10, or tumour necrosis factor-alpha levels in the blood, or in cognitive performance or mood between the treatment and placebo groups.
T15 1680-1839 Sentence denotes Despite the small increase observed in HDL cholesterol, the polyphenol-rich seaweed extract did not change CVD risk factors in adults with high fasting lipids.
T16 1840-1947 Sentence denotes A larger sample size would be required to confirm the clinical relevance of the changes in HDL cholesterol.